Immunomodulating Effects of the Anti-Viral Agent Silibinin in Liver Transplant Patients With HCV Recurrence

Transplantation Research - United Kingdom
doi 10.1186/s13737-016-0030-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Severity of Liver Disease Affects HCV Kinetics in Patients Treated With Intravenous Silibinin Monotherapy

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Anti-Inflammatory and Immunomodulating Effects of Clarithromycin in Patients With Cystic Fibrosis Lung Disease

Mediators of Inflammation
ImmunologyCell Biology
2004English

Optimization of Direct Anti-Viral Agent Treatment Schedule: Focus on HCV Genotype 3

United European Gastroenterology Journal
OncologyGastroenterology
2017English

HCV Eradication With New IFN Free Treatment Improves Metabolic Profile in HCV-related Liver Transplant Recipients

Liver Transplantation
HepatologyTransplantationSurgery
2018English

Visceral Adiposity Increases Risk for Hepatocellular Carcinoma in Male Patients With Cirrhosis and Recurrence After Liver Transplant

Hepatology
MedicineHepatology
2018English

Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis

Annals of Transplantation
MedicineTransplantation
2018English

Remodeling of the Pulmonary Circulation in Patients With Viral Liver Cirrhosis

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2019English

Determination of HCV Genotypes and Viral Loads in Chronic HCV Infected Patients of Hazara Pakistan

Virology Journal
VirologyInfectious Diseases
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy